https://www.marketscreener.com/quote/stock/BIOXYTRAN-INC-117540343/news/Bioxytran-Inc-S-Oral-Antiviral-Drug-to-Enter-Dose-Optimization-Clinical-Trial-for-Covid-19-46007474/?utm_source=telegram&utm_medium=social&utm_campaign=share